FDA Regulation of Clinical Microbiology and AST Diagnostic Devices

“FDA Regulation of Clinical Microbiology and AST Diagnostic Devices”

Ribhi Shawar of FDA joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss ‘FDA regulation of clinical microbiology and AST diagnostic devices’ .

In this presentation, learn about some examples of challenges in data presentation/analysis as well as scientific and regulatory process understanding.

Download the presentation to understand more about:

  • Progress in microbial diagnostics, including AMR
  • Highlights of efforts and initiatives
  • Efforts on coordinated development between CDRH and CDER
  • The joint interagency FDA/CDC: Antimicrobial-Resistant Isolates Bank
  • Curated Genomic Sequence Debates
  • Resources

..and much more!

Get your copy here!

To find out more about progress in AMR diagnostics and the efforts of the FDA against AMR , attend World Anti-Microbial Resistance Congress USA 2016 held September 8-9 in Washington, DC .

Attend World Anti-Microbial Resistance USA 2016

Leave a Reply

Your email address will not be published. Required fields are marked *